GCN2 and perk kinase inhibitors and methods of use thereof | Patent Application Number 17528478

17528478
Not Appealed
Patent NumberUS 11912668 B2
Publication NumberUS 20220274934 A1
Filled DateNov 17, 2021
Priority Date-
Inventor/ApplicantsSalim Javed
Daniel L. Flynn
Bertrand LeBourdonnec
Bertrand Le Bourdonnec
Patrick Kearney
Yu Mi Ahn
Kristen Stoltz
Gada AI-Ani
Jeffery Zwicker
Gada Al-Ani
ExaminesMCDOWELL, BRIAN E
Art Unit1624
Technology Center1600
Assignments
Deciphera Pharmaceuticals Llc
Current
Deciphera Pharmaceuticals Llc
Original
Law Firm
You must be logged in to view
Login
Attorneys
Subscription-Only
View Concierge Program
Patent Prosecution report image

Empower your practice with Patexia Publication Prosecution IP Module.

Get access to our exclusive rankings and unlock powerful data.
Check our Latest ReportPurchase IP Module

Looking for a Publication Attorney?

Get in touch with our team or create your account to start exploring a network of over 120K attorneys.